• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 致死病例的完整尸检数据:临床、影像学和病理学相关性。

Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlations.

机构信息

Forensic Medicine Department, University Hospital, 30 Boulevard Jean Monnet, Nantes, 44000, France.

Department of Radiology, University Hospital, Nantes, France.

出版信息

Int J Legal Med. 2020 Nov;134(6):2209-2214. doi: 10.1007/s00414-020-02390-1. Epub 2020 Aug 6.

DOI:10.1007/s00414-020-02390-1
PMID:32767018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7410356/
Abstract

A 75-year-old man presented to a French hospital with a 4-day fever after returning from a coronavirus disease-19 (COVID-19) cluster region. A reverse-transcription polymerase chain reaction test was positive for severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) using a nasopharyngeal swab sample. After he returned home and a telephone follow-up, he was found deceased 9 days after first showing symptoms. Whole-body, non-enhanced, post-mortem computed tomography (PMCT) and a forensic autopsy were performed approximately 48 h after death, with sanitary precautions. The PMCT showed bilateral and diffuse crazy-paving lung opacities, with bilateral pleural effusions. Post-mortem virology studies detected the presence of SARS-CoV-2 (B.1 lineage) in the nasopharynx, plasma, lung biopsies, pleural effusion and faeces confirming the persistence of viral ribonucleic acid 48 h after death. Microscopic examination showed that severe lung damage was responsible for his death. The main abnormality was diffuse alveolar damage, associated with different stages of inflammation and fibrosis. This case is one of the first to describe complete post-mortem data for a COVID-19 death and highlights the ability of PMCT to detect severe involvement of the lungs before autopsy in an apparently natural death. The present pathology results are concordant with previously reported findings and reinforce the disease pathogenesis hypothesis of combined viral replication with an inappropriate immune response.

摘要

一位 75 岁男性,从 COVID-19 聚集地区返回后出现发热 4 天,前往法国一家医院就诊。使用鼻咽拭子样本进行逆转录聚合酶链反应检测,结果 SARS-CoV-2(严重急性呼吸综合征冠状病毒 2)呈阳性。他返回家中并接受电话随访后,在首次出现症状 9 天后死亡。在死亡后大约 48 小时,进行了全身非增强型死后 CT(PMCT)和法医尸检,并采取了卫生防护措施。PMCT 显示双肺双侧弥漫性铺路石样混浊,伴有双侧胸腔积液。死后病毒学研究在鼻咽部、血浆、肺活检、胸腔积液和粪便中均检测到 SARS-CoV-2(B.1 谱系)的存在,证实病毒核糖核酸在死亡后 48 小时仍存在。显微镜检查显示严重的肺部损伤是导致他死亡的原因。主要异常是弥漫性肺泡损伤,伴有不同阶段的炎症和纤维化。这是首例描述 COVID-19 死亡后完整尸检数据的病例之一,强调了 PMCT 在自然死亡的情况下,在尸检前能够检测到肺部的严重受累。目前的病理结果与先前报道的结果一致,进一步证实了病毒复制与免疫反应失调相结合的疾病发病机制假说。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6f/7410356/592498f27666/414_2020_2390_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6f/7410356/bd6400d5b852/414_2020_2390_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6f/7410356/194ff6720b7a/414_2020_2390_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6f/7410356/592498f27666/414_2020_2390_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6f/7410356/bd6400d5b852/414_2020_2390_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6f/7410356/194ff6720b7a/414_2020_2390_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6f/7410356/592498f27666/414_2020_2390_Fig3_HTML.jpg

相似文献

1
Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlations.COVID-19 致死病例的完整尸检数据:临床、影像学和病理学相关性。
Int J Legal Med. 2020 Nov;134(6):2209-2214. doi: 10.1007/s00414-020-02390-1. Epub 2020 Aug 6.
2
[Findings in post-mortem CT and autopsy in a 53-year-old-man with COVID-19].[一名53岁新冠肺炎男性患者的尸检CT及尸检结果]
Ugeskr Laeger. 2020 Jul 6;182(28).
3
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.肺泡巨噬细胞功能障碍和细胞因子风暴在两例严重 COVID-19 患者发病机制中的作用。
EBioMedicine. 2020 Jul;57:102833. doi: 10.1016/j.ebiom.2020.102833. Epub 2020 Jun 20.
4
Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation.在隔离期间,与 COVID-19 相关的死亡病例的大体和组织病理学肺部观察结果。
Int J Legal Med. 2020 Jul;134(4):1285-1290. doi: 10.1007/s00414-020-02319-8. Epub 2020 Jun 5.
5
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.死于 SARS-CoV-2 感染——德国汉堡首例连续 80 例尸检研究。
Int J Legal Med. 2020 Jul;134(4):1275-1284. doi: 10.1007/s00414-020-02317-w. Epub 2020 Jun 4.
6
Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients.弥漫性肺泡损伤和血栓性微血管病是 COVID-19 患者肺组织活检样本中的主要组织病理学发现。
Pathol Res Pract. 2020 Oct;216(10):153228. doi: 10.1016/j.prp.2020.153228. Epub 2020 Sep 19.
7
COVID-19 Autopsies, Oklahoma, USA.美国俄克拉荷马州的 COVID-19 尸检。
Am J Clin Pathol. 2020 May 5;153(6):725-733. doi: 10.1093/ajcp/aqaa062.
8
Clinical and radiological features of novel coronavirus pneumonia.新型冠状病毒肺炎的临床和影像学特征。
J Xray Sci Technol. 2020;28(3):391-404. doi: 10.3233/XST-200687.
9
Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.华盛顿州致命性 COVID-19 感染的组织病理学和超微结构发现:病例系列研究。
Lancet. 2020 Aug 1;396(10247):320-332. doi: 10.1016/S0140-6736(20)31305-2. Epub 2020 Jul 16.
10
Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan.日本 COVID-19 患者尸检的临床病理和免疫组织化学检查结果。
Emerg Infect Dis. 2020 Sep;26(9):2157-61. doi: 10.3201/eid2609.201353. Epub 2020 May 15.

引用本文的文献

1
Protein profiling in intensive care unit-treated COVID-19 patients identifies biomarkers of residual lung abnormalities.重症监护病房治疗的新冠肺炎患者的蛋白质谱分析确定了残留肺部异常的生物标志物。
ERJ Open Res. 2025 Jun 23;11(3). doi: 10.1183/23120541.00981-2024. eCollection 2025 May.
2
The current state of forensic imaging - post mortem imaging.法医成像的现状——尸体剖验成像
Int J Legal Med. 2025 May;139(3):1141-1159. doi: 10.1007/s00414-025-03461-x. Epub 2025 Mar 24.
3
Six and twelve-month respiratory outcomes in a cohort of severe and critical COVID-19 survivors: A prospective monocentric study in Latin America.

本文引用的文献

1
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.意大利北部一系列 COVID-19 病例的肺脏尸检结果:一项两中心描述性研究。
Lancet Infect Dis. 2020 Oct;20(10):1135-1140. doi: 10.1016/S1473-3099(20)30434-5. Epub 2020 Jun 8.
2
Emergence of genomic diversity and recurrent mutations in SARS-CoV-2.新冠病毒基因组多样性和反复出现的突变。
Infect Genet Evol. 2020 Sep;83:104351. doi: 10.1016/j.meegid.2020.104351. Epub 2020 May 5.
3
Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected with Pulmonary CT Angiography.
一组重症和危重症新冠病毒疾病幸存者的6个月和12个月呼吸结局:拉丁美洲一项前瞻性单中心研究
SAGE Open Med. 2024 Sep 9;12:20503121241275369. doi: 10.1177/20503121241275369. eCollection 2024.
4
A follow-up study of post-COVID-19 syndrome in hospitalized children with Omicron variant infection in Wuhan.武汉奥密克戎变异株感染住院儿童新冠后综合征的随访研究
Front Pediatr. 2024 Aug 1;12:1359057. doi: 10.3389/fped.2024.1359057. eCollection 2024.
5
Crucial role played by CK8 cells in mediating alveolar injury remodeling for patients with COVID-19.CK8 细胞在介导 COVID-19 患者肺泡损伤重塑中的关键作用。
Virol Sin. 2024 Jun;39(3):390-402. doi: 10.1016/j.virs.2024.03.007. Epub 2024 Mar 21.
6
Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease.新型冠状病毒肺炎的肺部后遗症:关注间质性肺疾病。
Cells. 2023 Sep 8;12(18):2238. doi: 10.3390/cells12182238.
7
Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up.重症新型冠状病毒肺炎后间质性肺疾病发生的危险因素及全身糖皮质激素治疗的结局:3个月随访
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Sep 13;40(3):e2023029. doi: 10.36141/svdld.v40i3.14418.
8
Post-COVID Interstitial Lung Disease-The Tip of the Iceberg.新冠后间质性肺病——冰山一角。
Immunol Allergy Clin North Am. 2023 May;43(2):389-410. doi: 10.1016/j.iac.2023.01.004. Epub 2023 Mar 3.
9
The trajectory of COVID-19 cardiopulmonary disease: insights from an autopsy study of community-based, pre-hospital deaths.新冠心肺疾病的病程:基于社区的院前死亡病例尸检研究的见解
ERJ Open Res. 2022 Dec 27;8(4). doi: 10.1183/23120541.00303-2022. eCollection 2022 Oct.
10
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study.新冠肺炎住院后肺部残留异常:英国 COVID-19 后研究的临时分析。
Am J Respir Crit Care Med. 2023 Mar 15;207(6):693-703. doi: 10.1164/rccm.202203-0564OC.
通过肺部CT血管造影术检测到的与COVID-19肺炎相关的急性肺栓塞
Radiology. 2020 Sep;296(3):E186-E188. doi: 10.1148/radiol.2020201544. Epub 2020 Apr 23.
4
SARS-CoV-2 and viral sepsis: observations and hypotheses.SARS-CoV-2 与病毒败血症:观察与假说。
Lancet. 2020 May 9;395(10235):1517-1520. doi: 10.1016/S0140-6736(20)30920-X. Epub 2020 Apr 17.
5
Nervous system involvement after infection with COVID-19 and other coronaviruses.感染 COVID-19 和其他冠状病毒后的神经系统并发症。
Brain Behav Immun. 2020 Jul;87:18-22. doi: 10.1016/j.bbi.2020.03.031. Epub 2020 Mar 30.
6
Autopsy in suspected COVID-19 cases.疑似 COVID-19 病例的尸检。
J Clin Pathol. 2020 May;73(5):239-242. doi: 10.1136/jclinpath-2020-206522. Epub 2020 Mar 20.
7
Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review.新型冠状病毒病 2019(COVID-19)的胸部 CT 表现:影像学综述。
Eur Radiol. 2020 Aug;30(8):4381-4389. doi: 10.1007/s00330-020-06801-0. Epub 2020 Mar 19.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study.新型冠状病毒肺炎的胸部 CT 表现与临床特征的关系:一项多中心研究。
AJR Am J Roentgenol. 2020 May;214(5):1072-1077. doi: 10.2214/AJR.20.22976. Epub 2020 Mar 3.
10
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer.两例肺癌患者 2019 年新型冠状病毒(COVID-19)肺炎早期阶段的肺部病理学表现。
J Thorac Oncol. 2020 May;15(5):700-704. doi: 10.1016/j.jtho.2020.02.010. Epub 2020 Feb 28.